Skip to content

Clinical and experimental study on preoperative selective portal vein embolization for hilar cholangiocarcinoma

Clinical and experimental study on preoperative selective portal vein embolization for hilar cholangiocarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-TNRC-08000104
Enrollment
Unknown
Registered
2008-05-26
Start date
2008-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hilar Cholangiocarcinoma

Interventions

PVE Group:Embolize the portal vein branch of liver lobe to be resected, after selective biliary drainage(SBD) of future liver remnant(FLR)
Un-PVE Group:The intervention measures are as the same as in PVE group except for PVE under standard procedure of diagnosis and treatment(SBD, volumetric CT, major hepatectomy).

Sponsors

Eastern Hepatobiliary Surgery Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with hilar cholangiocarcinoma diagnosed with CT/MRI, beyond Bismuth type II, without severe disease of other major organs, and to be resected combined with major hepatectomy/extra hemihepatectomy

Exclusion criteria

Exclusion criteria: Patients with hilar cholangiocarcinoma resected not combined with major hepatectomy/extra hemihepatectomy

Design outcomes

Primary

MeasureTime frame
Liver volumetric measurement;Portal vein pressure;Blood flow velocity and rate of portal vein;Operation prognostic inde;

Secondary

MeasureTime frame
Pathological index;Liver regeneration indexs;

Countries

China

Contacts

Public ContactYi Bin
billyyi11@163.com+86 0 13916199606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026